Competition Committee reviews complaints about forced purchase of medicines in wholesale procurement
Uzbekistan's Committee for the Development of Competition and Protection of Consumer Rights is reviewing complaints that importers and wholesale distributors, when selling in-demand medicines, require the purchase of additional, unrequested drugs. Over the first nine months of 2026, medicines were imported by 305 enterprises, with 47.2% of imports accounted for by five companies. A violation of the Law 'On Competition' carries a fine of up to 5% of revenue.
Javlon Tursunov